These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38615028)

  • 21. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline.
    Pan FF; Huang L; Chen KL; Zhao QH; Guo QH
    BMC Neurol; 2020 Mar; 20(1):78. PubMed ID: 32138678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
    Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
    Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.
    Wang X; Li F; Tian J; Gao Q; Zhu H
    Eur J Med Res; 2023 Oct; 28(1):427. PubMed ID: 37821912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring Potential Electrophysiological Biomarkers in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.
    Gu L; Zhang Z
    J Alzheimers Dis; 2017; 58(4):1283-1292. PubMed ID: 28550252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué-Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010783. PubMed ID: 34313331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural Dynamics of Multiple Object Processing in Mild Cognitive Impairment and Alzheimer's Disease: Future Early Diagnostic Biomarkers?
    Bagattini C; Mazza V; Panizza L; Ferrari C; Bonomini C; Brignani D
    J Alzheimers Dis; 2017; 59(2):643-654. PubMed ID: 28671112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EEG asymmetry and cognitive testing in MCI identification.
    Martin T; Giordani B; Kavcic V
    Int J Psychophysiol; 2022 Jul; 177():213-219. PubMed ID: 35618112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the potential of combining transcranial magnetic stimulation and electroencephalography to investigate mild cognitive impairment and Alzheimer's disease: a systematic review.
    Hall JD; Green JM; Chen YA; Liu Y; Zhang H; Sundman MH; Chou YH
    Geroscience; 2024 Aug; 46(4):3659-3693. PubMed ID: 38356029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia.
    Park JI;
    Psychogeriatrics; 2024 May; 24(3):555-564. PubMed ID: 38403289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's disease.
    McBride JC; Zhao X; Munro NB; Smith CD; Jicha GA; Hively L; Broster LS; Schmitt FA; Kryscio RJ; Jiang Y
    Comput Methods Programs Biomed; 2014 Apr; 114(2):153-63. PubMed ID: 24598317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digital Clock and Recall is superior to the Mini-Mental State Examination for the detection of mild cognitive impairment and mild dementia.
    Jannati A; Toro-Serey C; Gomes-Osman J; Banks R; Ciesla M; Showalter J; Bates D; Tobyne S; Pascual-Leone A
    Alzheimers Res Ther; 2024 Jan; 16(1):2. PubMed ID: 38167251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild Cognitive Impairment Is Characterized by Deficient Brainstem and Cortical Representations of Speech.
    Bidelman GM; Lowther JE; Tak SH; Alain C
    J Neurosci; 2017 Mar; 37(13):3610-3620. PubMed ID: 28270574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.
    Pietto M; Parra MA; Trujillo N; Flores F; García AM; Bustin J; Richly P; Manes F; Lopera F; Ibáñez A; Baez S
    J Alzheimers Dis; 2016 Jun; 53(4):1325-40. PubMed ID: 27372640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.
    Bondi MW; Edmonds EC; Jak AJ; Clark LR; Delano-Wood L; McDonald CR; Nation DA; Libon DJ; Au R; Galasko D; Salmon DP
    J Alzheimers Dis; 2014; 42(1):275-89. PubMed ID: 24844687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer's disease using EEG technology.
    Jiao B; Li R; Zhou H; Qing K; Liu H; Pan H; Lei Y; Fu W; Wang X; Xiao X; Liu X; Yang Q; Liao X; Zhou Y; Fang L; Dong Y; Yang Y; Jiang H; Huang S; Shen L
    Alzheimers Res Ther; 2023 Feb; 15(1):32. PubMed ID: 36765411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer's dementia.
    Azami H; Zrenner C; Brooks H; Zomorrodi R; Blumberger DM; Fischer CE; Flint A; Herrmann N; Kumar S; Lanctôt K; Mah L; Mulsant BH; Pollock BG; Rajji TK;
    Alzheimers Res Ther; 2023 Aug; 15(1):133. PubMed ID: 37550778
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.